ADC Therapeutics
ADCT
ADCT
77 hedge funds and large institutions have $173M invested in ADC Therapeutics in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 74 → 77 (+3)
2.91% more ownership
Funds ownership: 53.85% → 56.76% (+2.9%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
77
Holding in Top 10
2
Calls
$265K
Puts
$110K
Top Buyers
1 | +$4.04M | |
2 | +$2.66M | |
3 | +$1.44M | |
4 |
RG
Redmile Group
San Francisco,
California
|
+$1.26M |
5 |
O
OrbiMed
New York
|
+$683K |
Top Sellers
1 | -$3.22M | |
2 | -$1.51M | |
3 | -$1.5M | |
4 |
AI
Atom Investors
Austin,
Texas
|
-$1.02M |
5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$604K |